Erschienen in:
01.04.2016 | Editorial
Choledocholithiasis Without Cholelithiasis: Should the Gallbladder Stay or Should It Go?
verfasst von:
Pritesh Mutha, Tilak Shah, Douglas Heuman, Alvin Zfass, Mitchell L. Schubert
Erschienen in:
Digestive Diseases and Sciences
|
Ausgabe 4/2016
Einloggen, um Zugang zu erhalten
Excerpt
Cholelithiasis (gallstones) is common, with an estimated prevalence of ~12 % of adult population in the USA. The prevalence, increasing with age, approaches 33 % in elderly women [
1]. Approximately 15 % of patients with cholelithiasis have concurrent choledocholithiasis (bile duct stones), and conversely, 95 % of patients with choledocholithiasis have cholelithiasis [
2,
3]. Although the natural history of asymptomatic common bile duct (CBD) stones is not well defined, they are thought to be less benign than asymptomatic gallbladder gallstones. Although CBD stones may pass uneventfully through the ampulla of Vater into the duodenum, their passage can induce acute pancreatitis and stone impaction at the distal bile duct, causing biliary colic and cholangitis. Because adverse events may be serious and life-threatening, it is generally recommended that CBD stones be removed. …
